Manganese
Pronunciation: MAN-ga-nees
Class: Trace metal
Trade Names
Manganese chloride
- Injection, solution manganese 0.1 mg/mL (as manganese chloride 0.36 mg/mL)
Manganese sulfate
- Injection, solution manganese 0.1 mg/mL (as manganese sulfate 0.308 mg/mL)
Pharmacology
Activator for enzymes such as polysaccharide polymerase, liver arginase, cholinesterase, and pyruvate carboxylase.
Pharmacokinetics
Distribution
Bound to transmanganin, a beta-1 globulin. Widely distributed but concentrates in the mitochondria-rich tissues such as brain, kidney, pancreas, and liver.
Elimination
Eliminated via the bile.
Indications and Usage
As a supplement to TPN to help maintain manganese plasma levels and to prevent depletion of endogenous stores and subsequent deficiency syndromes.
Contraindications
Do not give undiluted by direct injection into a peripheral vein; do not give manganese chloride by direct IM or IV injection.
Dosage and Administration
Supplementation in Patients Receiving TPNAdults
IV 0.15 to 0.8 mg/day of manganese added to the TPN.
ChildrenIV 2 to 10 mcg/kg/day of manganese added to the TPN.
Hepatic Function ImpairmentOmit or reduce dose as needed in patients with liver dysfunction and/or biliary tract dysfunction.
General Advice
- Do not give undiluted by direct injection into a peripheral vein.
- Do not give manganese chloride by direct IM or IV injection.
- Add to TPN solution.
Storage/Stability
Store between 59° and 86°F.
Drug Interactions
None well documented.
Adverse Reactions
Adverse reactions are unlikely to occur at the recommended dosage levels.
Precautions
MonitorPeriodic monitoring of manganese plasma levels is suggested as a guideline for subsequent administration. |
Pregnancy
Category C.
Lactation
Undetermined.
Elderly
Use with caution.
Hepatic Function
Excreted in the bile; adjust or omit dose as needed in patients with hepatic dysfunction and/or biliary tract dysfunction (eg, bile duct obstruction).
Aluminum toxicity
Parenteral products may contain aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk.
Overdosage
Symptoms
None well documented.
Patient Information
- Advise patient that medication will be prepared and administered by a health care provider in a hospital setting.
Copyright © 2009 Wolters Kluwer Health.


